Angiodynamics (ANGO) Change in Receivables (2010 - 2026)

Angiodynamics' Change in Receivables history runs 17 years deep, the most recent figure standing at $2.9 million for Q2 2026.

• Quarterly Change in Receivables rose 749.44% year-over-year to $2.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $5.8 million (up 25100.0% YoY) and the FY2026 annual result came in at $5.8 million, up 25100.0% from the prior year.
• Change in Receivables was $2.9 million for Q2 2026 at Angiodynamics, up from $1.4 million in the prior quarter.
• Across five years, Change in Receivables topped out at $10.7 million in Q2 2022 and bottomed at -$5.5 million in Q2 2024.
• A 5-year average of $742277.8 and a median of $946000.0 in 2025 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2022 — Change in Receivables soared 3858.33% — and 2024, when it plunged 369.63%.
• Angiodynamics' Change in Receivables stood at -$406000.0 in 2022, then soared by 710.84% to $2.5 million in 2023, then soared by 50.56% to $3.7 million in 2024, then sank by 58.01% to $1.6 million in 2025, then surged by 85.14% to $2.9 million in 2026.
• Business Quant data shows ANGO's Change in Receivables at $2.9 million in Q2 2026, $1.4 million in Q1 2026, and $1.6 million in Q4 2025.